DIABETESpredict™ is a laboratory test which provides a high-sensitivity and –specificity evaluation of the genetic predisposition to develop type 2 diabetes (T2D). Furthermore, it offers personalized recommendations based on the patient’s genetic profile.
The test was developed in collaboration with scientists and endocrinologists at The Massachusetts General Hospital (Boston, MA) and The Broad Institute of MIT & Harvard (Cambridge, MA).
Patia is creating a new tool for the evaluation of genetic predisposition to suffer from gestational diabetes.
Knowing the genetic risk of suffering from this form of diabetes can avoid complications during pregnancy and in the newborn and prevent the appearance of type 2 diabetes in the future for both mother and baby.
Find out more about GDMpredict